EN
HI
Summary
As of 30 Aug, 2026, Jubilant Pharmova stock price is ₹882.65. During the trading session, the stock has moved between an intraday low of ₹871.10 and an intraday high of ₹895.00. Over the last 52 weeks, Jubilant Pharmova has traded between ₹786.05 and ₹1184.80.
The stock has recorded a trading volume of 1,24,044 shares, with a market capitalization of ₹159281139. Its Average Traded Price (ATP) is ₹884.97, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹882.65.
Jubilant Pharmova has an upper circuit limit of ₹1059.15 and a lower circuit limit of ₹706.15. The total value traded stands at ₹10.98 CR, and the delivery percentage for the day is 54.28%.
The stock is currently traded with a market lot size of 1. Jubilant Pharmova also offers a dividend yield of 0.57%.
Jubilant Pharmova share price chart
Jubilant Pharmova Share Key Metrics
Volume
1.24 L
Market Cap
14058.95 CR
LTQ@LTP
6@882.65
ATP
884.97
Var Margin
16.68 %
Circuit Range
706.15-1059.15
Delivery %
54.28 %
Value
10.98 CR
ASM/GSM
No
Market Lot
1
Jubilant Pharmova Fundamentals
P/E Ratio
39.9
P/B Ratio
1.97
Div. Yield
0.57
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Jubilant Pharmova Resistance and Support
Pivot 882.82
Resistance
First Resistance
890.64
Second Resistance
902.57
Third Resistance
910.39
Support
First Support
870.89
Second Support
863.07
Third Support
851.14
Jubilant Pharmova Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 880 | 882.65 | 0.45% | 895 | 871.1 |
| Thu Aug 27 2026 | 887.4 | 878.7 | -0.98% | 894.75 | 875 |
| Wed Aug 26 2026 | 902.04 | 887.4 | -1.03% | 908.45 | 881.25 |
Jubilant Pharmova Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-16 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
Jubilant Pharmova News
Jubilant Pharmova Ltd - 530019 - Receipt Of Show Cause Notice - Jubilant Generics Limited
Jubilant Pharmova's wholly-owned subsidiary, Jubilant Generics Limited, received a show-cause notice from the Joint Commissioner, CGST Division, Roorkee. The notice proposes a demand of Rs. 52.75 crore in GST and an equal penalty of Rs. 52.75 crore, totaling Rs. 105.5 crore, along with unquantified interest for FY 2020-21 and 2021-22, regarding alleged inadmissible IGST refund. The company will file a detailed reply.
Aug 28 2026 10:08:18
Jubilant Pharmova Ltd - 530019 - USFDA Approval For Line 3, Contract Manufacturing Facility, Spokane, U.S.A
Jubilant Pharmova announced that USFDA has approved commercial batch manufacturing on Line 3 of its Jubilant HollisterStier LLC contract manufacturing facility in Spokane, USA. This approval enables the production of the first product on the new isolator-based fill and finish line.
Aug 23 2026 00:39:51
Read More
Jubilant Pharmova Management
| Name | Position |
|---|---|
| Naresh Kapoor | Company Secretary & Compliance Officer |
| Shyam S Bhartia | Chairman |
Jubilant Pharmova Similar Stocks
Vijaya Diagnostic Centre Ltd.
1452.50
-19.90 (1.35%)
Marksans Pharma Ltd.
329.70
3.55 (1.09%)
Rainbow Children's Medicare Ltd.
1442.80
1.80 (0.12%)
Molbio Diagnostics Ltd.
1094.75
-49.40 (4.32%)
CORONA Remedies Ltd.
2079.50
-3.70 (0.18%)
Sudeep Pharma Ltd.
1152.10
18.00 (1.59%)
Alivus Life Sciences Ltd.
1350.20
-8.00 (0.59%)
Park Medi World Ltd.
290.55
0.40 (0.14%)
Akums Drugs & Pharmaceuticals Ltd.
772.60
11.40 (1.50%)
Jubilant Pharmova FAQs
The Buying Price of Jubilant Pharmova share is 882.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jubilant Pharmova stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jubilant Pharmova, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jubilant Pharmova shares is 39.9. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jubilant Pharmova shares is 1.97. Useful to assess the stock's value relative to its book value.
To assess Jubilant Pharmova’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jubilant Pharmova is 14058.95 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jubilant Pharmova share price is 1184.80 & 786.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jubilant Pharmova belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JUBLPHARMA
Or Download Choice FinX App
Invest in JUBLPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade